How to Calculate FIB-4 Score
The FIB-4 score is calculated using the formula: Age (years) × AST (U/L) / [Platelets (10^9/L) × √ALT (U/L)] 1
Formula Breakdown
The FIB-4 calculation requires four parameters:
- Age in years
- AST (aspartate aminotransferase) in U/L
- ALT (alanine aminotransferase) in U/L
- Platelet count in 10^9/L
The steps to calculate FIB-4 are:
- Multiply the patient's age (in years) by AST value
- Calculate the square root of ALT
- Multiply the platelet count by the square root of ALT
- Divide the result from step 1 by the result from step 3
Interpretation of FIB-4 Results
FIB-4 scores are interpreted using established cutoff values:
- < 1.3: Low probability of advanced liver fibrosis (negative predictive value of 90%) 1, 2
- 1.3-2.67: Indeterminate range, may require additional testing 1
- > 2.67: High probability of advanced liver fibrosis (accuracy of 80%) 1
- > 3.25: Strongly suggestive of advanced fibrosis (positive predictive value of 65%) 1
Clinical Applications
FIB-4 is widely used for:
- Non-invasive assessment of liver fibrosis in chronic liver diseases including:
Advantages and Limitations
Advantages:
- Simple calculation using routine laboratory parameters
- No additional cost beyond standard blood tests
- Validated in multiple populations 1
- Recommended by clinical practice guidelines as a first-line non-invasive test 1, 2
Limitations:
- Intermediate results may require additional testing such as transient elastography or liver biopsy 1
- Performance may vary between different liver diseases 1
- Less accurate than specialized imaging techniques like MR elastography 1
Clinical Recommendations
- FIB-4 should be used as an initial screening tool for liver fibrosis assessment 1, 2
- For indeterminate results, consider additional non-invasive tests like transient elastography 1
- Serial FIB-4 measurements can help monitor fibrosis progression over time 3
- A FIB-4 score < 1.3 reliably excludes advanced fibrosis with a negative predictive value ≥90% 2
Remember that while FIB-4 is a valuable non-invasive tool, liver biopsy remains the gold standard for definitive assessment of liver fibrosis in cases where non-invasive tests yield inconclusive results or when additional histological information is needed 1.